Occam Sciences Overview
- Founded
- 2011
- Status
- Private
- Latest Deal Type
- Seed
- Latest Deal Amount
- $300K
- Investors
- 2
Occam Sciences General Information
Description
Provider of therapeutic drug development services intended to offer bio-available forms of approved drugs. The company's services include developing drugs using green chemistry to design drugs that are bioavailable, enabling researchers to develop oral drugs.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 33 Whitney Street
- New Haven, CT 06510
- United States
+1 (203) 000-0000
Occam Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 21-Oct-2011 | $300K | 00000 | Completed | Startup |
Occam Sciences Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Robert Bettigole | Chief Executive Officer, President, Treasurer & Chairman |
Occam Sciences Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Brian Dixon | Occam Sciences | Board Member | 000 0000 |
| David Whittaker MD | Elm Street Ventures | Board Member | 000 0000 |
| John Warner | Occam Sciences | Board Member | 000 0000 |
| Joseph Pont | Occam Sciences | Board Member | 000 0000 |
| Robert Bettigole | Self | Chief Executive Officer, President, Treasurer & Chairman | 000 0000 |
Occam Sciences Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Elm Street Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Warner Babcock Institute for Green Chemistry | Other | Minority | 000 0000 | 000000 0 |